Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PITAVASTATIN vs PLACEBO: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PITAVASTATIN vs PLACEBO: Safety Overview

Metric PITAVASTATIN PLACEBO
Total FAERS Reports 2,344 312
Deaths Reported 346 30
Death Rate 14.8% 9.6%
Hospitalizations 351 223
Average Patient Age 65.1 yrs 59.9 yrs
% Female Patients 56.0% 61.8%
FDA Approval Date Apr 30, 2024 N/A
Manufacturer Aurobindo Pharma Limited N/A
Route ORAL N/A
Marketing Status Prescription N/A